Stay updated on Risankizumab Maintenance in Psoriasis Clinical Trial

Sign up to get notified when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Risankizumab Maintenance in Psoriasis Clinical Trial page

  1. Check
    2 days ago
    Change Detected
    Summary
    Added 'State of Vienna' as the location designation and updated Vienna addresses to 'Vienna, State of Vienna, Austria, 1030' and '1090', replacing the previous 'Vienna' entries. Also updated the page revision from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-20T05:14:03.000Z thumbnail image
  2. Check
    9 days ago
    No Change Detected
  3. Check
    16 days ago
    No Change Detected
  4. Check
    31 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0. The study details and page layout appear unchanged.
    Difference
    0.0%
    Check dated 2026-03-22T11:26:06.000Z thumbnail image
  5. Check
    45 days ago
    Change Detected
    Summary
    - Revision metadata updated: added v3.4.3 and removed v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-08T03:54:33.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T13:12:15.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.0 to v3.4.1. This appears to be a versioning update to the documentation with no changes to the study details.
    Difference
    0.0%
    Check dated 2026-02-07T07:32:54.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added: Show glossary; Last Update Submitted that Met QC Criteria; No FEAR Act Data; Revision: v3.4.0; Removed: Last Update Submitted that met QC Criteria; No FEAR Act data; Revision: v3.3.4. These changes affect only UI text and metadata and do not alter substantive study information, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-01-24T04:55:48.000Z thumbnail image

Stay in the know with updates to Risankizumab Maintenance in Psoriasis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Risankizumab Maintenance in Psoriasis Clinical Trial page.